Whilst discount playing cards might help relieve the burden of high drug expenses within the short term, they do not handle the systemic challenges driving up prescription selling prices from the U.S. Broader policy modifications could tackle the root results in of increasing drug selling prices, which include lack of transparency in pricing as wel